SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Del Corno, M. Articles by Collman, R. G. Search for Related Content PubMed PubMed Citation Articles by Del Corno, M. Articles by Collman, R. G. Related Collections Signal Transduction Chemokines, Cytokines, and Interleukins Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 November 2001, Vol. 98, No. 10, pp. 2909-2916 CHEMOKINES HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling Manuela Del Corno, Qing-Hua Liu, Dominique Schols, Erik de Clercq, Sandra Gessani, Bruce D. Freedman, and Ronald G. Collman From the Department of Medicine, University of Pennsylvania School of Medicine, and Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA; Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium; and Laboratory of Virology, Istituto Superiore di Sanita', Rome, Italy.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Human immunodeficiency virus type 1 (HIV-1) uses the chemokine receptors CCR5 and CXCR4 as coreceptors for entry. It was recently demonstrated that HIV-1 glycoprotein 120 (gp120) elevated calcium and activated several ionic signaling responses in primary human macrophages, which are important targets for HIV-1 in vivo. This study shows that chemokine receptor engagement by both CCR5-dependent (R5) and CXCR4-dependent (X4) gp120 led to rapid phosphorylation of the focal adhesion-related tyrosine kinase Pyk2 in macrophages. Pyk2 phosphorylation was also induced by macrophage inflammatory protein-1 (MIP-1) and stromal cell-derived factor-1, chemokine ligands for CCR5 and CXCR4. Activation was blocked by EGTA and by a potent blocker of calcium release-activated Ca++ (CRAC) channels, but was insensitive to pertussis toxin (PTX), implicating CRAC-mediated extracellular Ca++ influx but not Gi protein-dependent mechanisms. Coreceptor engagement by gp120 and chemokines also activated 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase/stress-activated protein kinase and p38 MAPK. Furthermore, gp120-stimulated macrophages secreted the chemokines monocyte chemotactic protein-1 and MIP-1 in a manner that was dependent on MAPK activation. Thus, the gp120 signaling cascade in macrophages includes coreceptor binding, PTX-insensitive signal transduction, ionic signaling including Ca++ influx, and activation of Pyk2 and MAPK pathways, and leads to secretion of inflammatory mediators. HIV-1 Env signaling through these pathways may contribute to dysregulation of uninfected macrophage functions, new target cell recruitment, or modulation of macrophage infection. (Blood. 2001;98:2909-2916) © 2001 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Human immunodeficiency virus type 1 (HIV-1) infection is initiated by the formation of a trimolecular complex on the cell surface, consisting of the HIV-1 envelope (Env) glycoprotein 120 (gp120), the principal cellular receptor CD4, and a chemokine receptor that functions as a coreceptor (reviewed by Berger1). Conformational changes induced in gp120 on binding to CD4 increase its affinity for the coreceptor, leading to fusion between the viral and cellular membranes. The chemokine receptors that serve as HIV coreceptors are members of the 7 transmembrane G protein-coupled receptor (GPCR) family. CCR5 and CXCR4 play a dominant role in HIV-1 entry into primary cells, and are the principal coreceptors used by macrophage (M)-tropic (R5) and T-cell line (T)-tropic (X4) isolates, respectively. Given their normal cell signaling function, the interaction of gp120 with the chemokine receptors may, in addition to facilitating viral entry, also result in activation of cellular responses that could modulate the activation status of the cells and affect postentry stages of HIV replication (reviewed by Popik and Pitha2). Although chemokine receptors and their ligands play central roles in both HIV infection and in immune regulation, how signaling pathways mediated by CCR5 and CXCR4 contribute to the immunopathogenesis of HIV infection is not well defined. In T cells, gp120 activation of the chemokine receptors has been shown to elevate calcium3 and activate the focal adhesion tyrosine kinases Pyk2 and FAK4-6 as well as the mitogen-activated protein kinase (MAPK) pathway.7,8 Macrophages are important targets for HIV-1 in vivo. Infected macrophages may serve as a reservoir for viral persistence and participate in person-to-person transmission and are central to the pathogenesis of brain, lung, and other end-organ disease in acquired immunodeficiency syndrome (AIDS).9-12 In addition, aberrant functions of both infected and uninfected macrophages have been implicated in pathogenesis.13-15 Macrophages express CCR5, which is used for entry by primary and prototype M-tropic R5 HIV-1 variants. Macrophages also express CXCR4, which mediates entry by some X4 and R5X4 primary isolates, although laboratory-adapted X4 strains are restricted in their ability to use macrophage CXCR4 for reasons that are not yet clear.16-18 However, relatively little is known about how the chemokine receptors are coupled to cellular signaling pathways in primary macrophages. Because the cellular signaling pathways activated through 7-transmembrane GPCRs may differ depending on the cell type,19 we have examined whether gp120 engagement of the chemokine receptors leads to activation signals in primary human macrophages. Recently we reported that Env activates several ion channels and elevates calcium in macrophages through CCR5 and CXCR4.20 In this study we examined the ability of chemokine receptor stimulation by gp120 to activate protein kinase pathways in primary macrophages, because protein phosphorylation is an important molecular mechanism by which extracellular signals produce biologic responses in cells. In addition, to address potential functional consequences of Env signaling in macrophages, we examined -chemokine secretion after gp120 stimulation. Our studies show that HIV-1 gp120 activates the focal adhesion-related kinase Pyk2 in primary human macrophages via CCR5 and CXCR4, stimulates phosphorylation of p38 and c-Jun amino terminal kinase/stress-activated protein kinase (JNK/SAPK) MAPKs, and leads to -chemokine secretion. These results help elucidate the pathways by which the chemokine receptors are linked in primary macrophages and provide insight into mechanisms by which HIV-1 may dysregulate macrophage functions and contribute to pathogenesis.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Primary human macrophages, Env glycoproteins, and chemokines Monocytes were isolated from peripheral blood mononuclear cells of healthy donors by a 2-stage selective adherence procedure as previously described.21 Monocytes were plated at 5 × 105 cells/well in 24-well tissue culture plates and maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 10% horse serum, L-glutamine (1 mM), penicillin (100 U/mL), and streptomycin (100 µg/mL), without exogenous cytokines or growth factors. Cells were cultured at 37°C under 5% CO2 for 1 week prior to study to allow differentiation into monocyte-derived macrophages (MDMs). Donors were screened for the CCR5 32 mutation by polymerase chain reaction,22 and only donors homozygous for the wild-type allele were used for these studies, except for specified experiments in which CCR5-deficient macrophages were obtained from donors homozygous for the mutant allele. Recombinant gp120 was produced as previously described23 in 293T cells infected with gp120-expressing recombinant vaccinia viruses vCB28 (JRFL) or vSC60 (IIIB, BH8 clone) and was a generous gift of R. Doms (University of Pennsylvania). Supernatants were clarified by centrifugation and filtered (0.45 µm pore size). Virus was inactivated (0.1% Triton X-100) and gp120 was purified using Galanthus nivalis lectin-coupled agarose beads (Vector Labs, Burlingame, CA) followed by protein concentration and buffer exchange. Env integrity was confirmed by Western blot with a rabbit polyclonal antibody as described.23 Chemokines signaling was investigated with macrophage inflammatory protein-1 (MIP-1) and stromal cell-derived factor-1 (SDF-1) (Peprotech, Rocky Hill, NJ). Cell treatment Twenty-four hours before exposure to gp120 or chemokines, MDM culture medium was removed and replaced with fresh media lacking serum to maintain the cells in a quiescent state. Macrophages were then exposed for the indicated periods of time at 37°C to either gp120 or chemokines (2.5 µg/mL and 200 nM, respectively, unless otherwise specified). Cells were then lysed and subjected to immunoprecipitation and immunoblot analysis. Cells were lysed in ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.4; 1% NP-40; 0.5% sodium deoxycholate; 150 mM NaCl; 0.1% sodium dodecyl sulfate [SDS]) supplemented with protease and phosphatase inhibitors (5 mM phenylmethylsulfonyl fluoride; 5 µg/mL pepstatin; 5 µg/mL leupeptin; 5 µg/mL aprotinin; 1 mM sodium vanadate; 1 mM sodium fluoride; 1 mM sodium pyrophosphate) and incubated for 10 minutes at 4°C. Cell lysates were then clarified by centrifugation at 13 000 rpm for 30 minutes at 4°C. Protein concentrations were determined by protein assay (Bio-Rad Laboratories, Hercules, CA). To test the effect of specific inhibitors, cells were treated prior to and during gp120 exposure with the CXCR4 antagonist AMD3100 (1 µg/mL); Bordetella pertussis toxin (PTX; 100 ng/mL; obtained from both Sigma, St Louis, MO, and Calbiochem, San Diego, CA); EGTA (2 mM; Sigma); and the calcium release-activated Ca++ (CRAC) channel blocker lanthanum chloride (100 nM; Sigma). Inhibitors were added to MDMs 20 to 60 minutes before gp120 exposure, except for PTX, which was added up to 18 hours before exposure. To ensure that inhibitory effects were not due to nonspecific toxicity, signaling antagonists were tested for cytotoxicity on human macrophages by vital staining using a methyl tetrazolium (MTT)-based assay (CellTiter AQ; Promega, Madison, WI). MDMs were plated at 5 × 104 cells/well in 96-well tissue culture. After 1 week in culture, medium was replaced with low serum medium (10% FBS) that was lacking phenol red. Test agents were added and cells were incubated for 18 hours. Tetrazolium reagent was then added and incubated for an additional 1 hour, and the optical density (OD; 492 nm) was determined using a plate spectrophotometer. Within each experiment a standard curve was established on the same plate by seeding MDMs at varying concentrations from 1 × 104 through 8 × 104 cells/well. The standard curve demonstrated a linear relationship between cell number and OD, and cytotoxicity was determined based on comparison with the standard curve. Five replicate wells were used to derive each data point. Immunoprecipitation and immunoblot analysis For Pyk2 immunoprecipitation, cell lysates containing identical amounts of protein (400 µg) from cells subjected to each treatment were clarified by incubation for 1 hour at 4°C with protein A+G-Sepharose (Santa Cruz Biotechnology; Santa Cruz, CA). Protein A+G-Sepharose was removed by centrifugation, and the supernatants were then incubated with 1 µg of the anti-Pyk2 monoclonal antibody (mAb) Pyk2/CAK (Transduction Laboratories; Lexington, KY) for 2 hours at 4°C. Antibody-antigen complexes were then immunoprecipitated by incubation for 2 hours at 4°C with 50 µL protein A+G-Sepharose (50% suspension) and then washed 3 times with lysis buffer and once with phosphate-buffered saline (PBS). Immunocomplexes were resuspended in Laemmli buffer, boiled for 5 minutes, and subjected to electrophoresis and immunoblotting. Immunoblot analysis was carried out on immunoprecipitates generated as described above or directly on cell lysates containing 40 µg protein that were mixed with an equal volume of 2 × Laemmli buffer and boiled for 5 minutes. Samples were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. The membranes were blocked overnight with 5% nonfat milk protein in PBS. They were then incubated sequentially with the primary specific antibody for 3 hours at room temperature or overnight at 4°C, washed, and then incubated with peroxidase-conjugated secondary antibody. The immunoreactive bands were visualized using enhanced chemiluminescence Western blotting system according to the manufacturer's instructions (Amersham, Piscataway, NJ). Blots were then stripped (2% SDS, 62.5 mM Tris, 100 mM -mercaptoethanol) for 30 minutes at 50°C and washed in PBS containing 0.05% Tween 20, before blocking and reprobing with primary antibody. Immunoblot detection was carried out using a 1:1000 dilution of antiphosphotyrosine mAb 4G10 (Upstate Biotechnology, Lake Placid, NY) in the case of Pyk2 immunoprecipitates. Whole cell extracts were analyzed using 0.5 µg/mL of a polyclonal antibody Anti-Pyk2 [pY402], which is specific for the Tyr402 phosporylated form of Pyk2 (Biosource International, Camarillo, CA), or 0.25 µg/mL mAb Pyk2/CAK, which detects total level of Pyk2 (Transduction Laboratories). MAPKs were detected using a 1:1000 dilution of polyclonal antibodies specific for Phospho-p38 [Thr180/Tyr182], Phospho-JNK/SAPK [Thr183/Tyr185], and Phosphop44/42 [Thr202/Tyr204], or a 1:1000 dilution of mAbs that detect total p38, JNK/SAPK, and ERK1/2 (all from Cell Signaling Technology, Beverly, MA). Peroxidase-conjugated secondary antibodies were used at a 1:3000 dilution (Amersham). Electrophoresis reagents and nitrocellulose membranes were obtained from Bio-Rad Laboratories. Measurement of chemokine secretion One-week-old macrophages were treated with gp120 (1 µg/mL) for 24 hours, in the presence or absence the MAPK-specific inhibitor SB-202190 (1 µg/mL; Calbiochem). Supernatant was clarified by centrifugation (5000 rpm for 5 minutes at 4°C) and stored at 80°C until analysis. Monocyte chemotactic protein-1 (MCP-1) and MIP-1 production in supernatant was measured by enzyme-linked immunoadsorbent assay (ELISA) as described by the manufacturer (R & D Systems; Minneapolis, MN). The detection limit for MCP-1 was 5 pg/mL and for MIP-1 4 pg/mL.     Results Top Abstract Introduction Materials and methods Results Discussion References JRFL gp120 activates Pyk2 kinase in primary human macrophages Pyk2 is a nonreceptor tyrosine kinase related to focal adhesion kinase (FAK) that is expressed mainly in cells of hematopoietic and neuronal lineage.24-26 Pyk2 can be activated by several growth factors, chemokines, and GPCR ligands, and on activation is phosphorylated at 4 tyrosine phosphorylation sites (Tyr402, 579, 580, 881), with Tyr402 as the major autophosphorylation site.27-31 To determine whether HIV-1 Env activates Pyk2 in primary human macrophages, we treated MDMs with recombinant gp120 from the R5 isolate JRFL and analyzed the levels of total and Tyr402-phosphorylated forms by combined immunoprecipitation and immunoblot using specific antibodies (Figure 1A). This analysis showed that MDMs express an abundance of total Pyk2 protein that had a molecular mobility of approximately 110 kd, in accord with prior studies of Pyk2 expression in monocytes.32 Exposure of macrophages to gp120 resulted in rapid Pyk2 tyrosine phosphorylation. We next determined the time course of Pyk2 activation using immunoblot analysis of whole cell lysates with antibodies specific for the total or activated forms of Pyk2. As shown in Figure 1B, MDMs responded to JRFL Env in a time-dependent manner. Pyk2 tyrosine phosphorylation generally peaked within 5 minutes and decreased to nearly background levels by about 30 minutes. Analysis of earlier time points demonstrated activation as early as 1 minute after stimulation and showed that maximal activation occurred approximately 5 minutes after treatment (data not shown). View larger version (26K): [in this window] [in a new window]   Figure 1. Tyrosine phosphorylation of Pyk2 in primary human macrophages occurs in response to HIV-1 R5 Env. (A) Week-old cultures of MDMs were unstimulated (CTR) or exposed for 5 minutes to JRFL gp120 (2.5 µg/mL), lysed, and subjected to immunoprecipitation with an anti-Pyk2 antibody. Immune complexes were resolved on 8% SDS-PAGE, transferred to a nitrocellulose membrane, and subjected to serial immunoblotting with an antiphosphotyrosine 4G10 antibody (upper panel) and an anti-Pyk2 antibody (lower panel). (B) MDMs were unstimulated (CTR) or exposed to JRFL gp120 (2.5 µg/mL) for the indicated times (minutes). Cell lysates were resolved by 8% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with anti-Pyk2 phosphospecific [pY402] antibody (upper panel, P-Pyk2). The same blot was then reprobed with an antibody specific for total Pyk2 (lower panel). Blots shown are representative of 5 independent experiments using different donors. Although MDMs from most donors had little or no basal Pyk2 phosphorylation and demonstrated a robust response to gp120 stimulation, there was some donor-to-donor variability in the level of constitutive Pyk2 phosphorylation under unstimulated conditions and the magnitude of phosphorylation response to gp120. In general, MDMs from donors that showed high levels of basal Pyk2 phosphorylation had relatively little up-regulation elicited by gp120 (data not shown). Interestingly, the higher levels of constitutive Pyk2 activation were seen primarily among MDMs from cigarette smokers, the significance of which is presently unknown, but for that reason MDMs from nonsmoker donors were used for further analysis. X4 gp120 as well as chemokines MIP-1 and SDF-1 activate Pyk2 in MDMs Even though primary macrophages are not permissive for prototype CXCR4-dependent HIV-1 strains, we and others recently showed that MDMs express CXCR4 and that macrophage CXCR4 is able to support entry by some primary X4 isolates.16-18 Furthermore, CXCR4 in macrophages is functionally coupled to ionic signaling pathways including those that regulate intracellular calcium.20,33 Therefore, we investigated whether X4 gp120 would also induce Pyk2 tyrosine phosphorylation in primary human macrophages. As shown in Figure 2A, Pyk2 phosphorylation was readily detected within 5 minutes after exposure to IIIB gp120. The overall levels of phosphorylated protein and the kinetics of activation were similar to those observed after JRFL gp120 stimulation. Thus, both R5 and X4 Env activate Pyk2 in primary macrophages. We observed the same Pyk2 activation pattern using several independent preparations of JRFL and IIIB gp120, and Pyk2 activation was completely abrogated when MDMs were treated with gp120 that had been subjected to heat inactivation (data not shown). View larger version (34K): [in this window] [in a new window]   Figure 2. X4 gp120 and chemokines induce macrophage Pyk2 tyrosine phosphorylation. Macrophages were stimulated for 5 minutes with 2.5 µg/mL X4 (IIIB) and R5 (JRFL) gp120 (A), or stimulated for the indicated time periods with 200 nM of the chemokines MIP-1 or SDF-1 (B). Cell lysates were resolved by 8% SDS-PAGE, transferred to a nitrocellulose membrane, and subjected to immunoblot analysis with an antibody specific for the phosphorylated form of Pyk2 (upper panels, P-Pyk2). The same blot was then reprobed with an antibody specific for total Pyk2 (lower panels). Each experiment was repeated at least 4 times and the presented blots are representative of these experiments. To test the effect of different agonist concentrations, macrophages were stimulated for 5 minutes with the indicated concentrations of gp120 (C) and MIP-1 (D), and analyzed by immunoblot as described above. We then tested whether macrophage chemokine receptor stimulation by the natural ligands would elicit Pyk2 activation responses similar to that seen with Env, using MIP-1, the most specific of several chemokines that signal through CCR5, and SDF-1, the only known CXCR4 ligand. Both MIP-1 and SDF-1 treatment led to Pyk2 tyrosine phosphorylation (Figure 2B). Thus, Pyk2 is activated in primary macrophages both by gp120, which binds CD4 and the chemokine receptors on the cell surface, and by MIP-1 and SDF-1, which activate CCR5 and CXCR4 independently of CD4. To address the concentration dependence of Pyk2 activation, we tested the effects of varying gp120 and chemokine concentrations (Figure 2C,D). For gp120, Pyk2 activation was seen with concentrations ranging from 0.25 to 2.5 µg/mL (2-20 nM), but not at 0.06 µg/mL (0.5 nM) or below (Figure 2C and data not shown). Pyk2 was activated by MIP-1 at concentrations of 200, 20, and 2 nM, but not by 0.5-nM concentration (Figure 2D). Thus, gp120 and MIP-1 at equimolar concentrations both activated Pyk2. Macrophage Pyk2 activation by R5 and X4 gp120 is mediated by CCR5 and CXCR4 We next investigated whether the chemokine receptors were responsible for gp120-induced Pyk2 activation in macrophages (Figure 3). To probe CXCR4 we used the bicyclam antagonist AMD3100, which blocks both the HIV-1 coreceptor function and SDF-1 signaling capability of CXCR4.34 The role of CCR5 was assessed using CCR5-deficient macrophages, obtained from donors homozygous for the CCR5 32 allele. This frameshift mutation in the 32 allele abrogates CCR5 surface expression and eliminates both its chemokine signaling and coreceptor function.22,35 View larger version (40K): [in this window] [in a new window]   Figure 3. CCR5 and CXCR4 mediate Pyk2 phosphorylation in primary human macrophages treated with HIV-1 gp120. (A) MDMs from a CCR5 wild-type donor were pretreated for 1 hour with (+) or without () the CXCR4 antagonist AMD3100 (1 µg/mL) before incubation for 5 minutes with R5 (JRFL) or X4 (IIIB) gp120 (2.5 µg/mL). (B) CCR5 MDMs derived from donors homozygous for the CCR5 32 deletion allele were treated for 5 minutes with JRFL or IIIB gp120 (2.5 µg/mL). Whole cell lysates were analyzed by immunoblotting with an antibody specific for the phosphorylated form of Pyk2 (upper panel, P-Pyk2) or with antibody specific for total Pyk2 (lower panel). Each experiment was repeated at least 3 times and the blots shown are representative of these experiments. Immunoblot analysis of macrophage lysates using antibodies specific for the activated or total forms of Pyk2 showed that in wild-type MDMs, the CXCR4 antagonist AMD3100 completely inhibited IIIB gp120-induced Pyk2 activation but had no effect on the responses to JRFL gp120 (Figure 3A). In contrast, macrophages lacking CCR5 exhibited reduced activation following JRFL gp120 exposure but responded to IIIB Env (Figure 3B). AMD3100 also blocked Pyk2 activation by SDF-1 but not by MIP-1, whereas CCR5 MDMs responded to SDF-1 but not MIP-1 (data not shown). Thus, R5 and X4 gp120 activation of Pyk2 in macrophages is specifically mediated by the Env glycoproteins' cognate coreceptors. Furthermore, because neither AMD3100 nor the absence of functional CCR5 would interfere with gp120 binding to CD4, these results also show that CD4 binding in the absence of chemokine receptor stimulation is not sufficient to activate Pyk2. Pyk2 activation is calcium-dependent but insensitive to PTX We next wished to address the mechanisms involved in gp120-elicited chemokine receptor-mediated Pyk2 activation in macrophages. In some cell systems Pyk2 phosphorylation is regulated by calcium,25,26,30,31,36 and we and others recently found that gp120 induces intracellular calcium elevations in MDMs.20,37 We therefore determined whether Pyk2 activation by JRFL gp120 is regulated by [Ca++]i elevations. As shown in Figure 4A, immunoblot analysis of macrophage cell lysates showed that chelation of extracellular calcium with EGTA blocked gp120-elicited Pyk2 tyrosine phosphorylation (Figure 4A). We then tested the effect of lanthanum, a potent inhibitor of the CRAC channels38 that are known to be expressed in macrophages.39 Lanthanum also suppressed the Env-induced activation response (Figure 4B). Taken together, these results suggest that intracellular calcium elevations due to calcium influx, elicited by JRFL through CCR5, is responsible for Pyk2 phosphorylation. View larger version (47K): [in this window] [in a new window]   Figure 4. Calcium signaling inhibitors but not PTX block gp120-induced tyrosine phosphorylation of Pyk2. MDMs were exposed for 5 minutes to JRFL gp120 (2.5 µg/mL) following (A) pretreatment for 20 minutes with or without 2 mM EGTA or (B) following pretreatment for 20 minutes with 100 nM lanthanum or for 18 hours with 100 ng/mL PTX. Whole cell lysates were then analyzed by immunoblotting with an antibody specific for the phosphorylated form of Pyk2 (upper panels, P-Pyk2) or with an antibody specific for total Pyk2 (lower panels). Blots shown are representative of 4 independent experiments using different donors. We then tested the effect on gp120-induced Pyk2 phosphorylation of PTX, which uncouples Gi proteins from G protein-linked 7-transmembrane receptors.40 JRFL Env-induced Pyk2 activation was not inhibited by PTX (Figure 4B). Furthermore, Pyk2 activation by MIP-1 was not blocked by PTX either (data not shown). Thus, CCR5 signaling in primary macrophages in response to both Env and chemokines is coupled through PTX-insensitive pathways and is therefore not mediated by Gi. JRFL gp120 and MIP-1 stimulate the MAP kinase pathway To address potential downstream consequences of gp120-induced Pyk2 activation in macrophages, we next focused on the MAPK family of signaling molecules (Figure 5). The MAPKs are a group of protein kinases that are activated in response to extracellular stimuli through dual phosphorylation at conserved threonine and tyrosine residues (reviewed by Cobb and Goldsmith41). In several non-macrophage cell types, it has been shown that Pyk2 acts upstream of the MAPK cascade.28,31,36,42,43 In lymphocytes, binding of gp120 to CCR5 has been reported to induce MAPK activation.7,8 View larger version (37K): [in this window] [in a new window]   Figure 5. JRFL gp120 induces MAPK activation in macrophages. MDMs were stimulated with JRFL gp120 (2.5 µg/mL) or MIP-1 (200 nM) for the indicated time periods. Cell lysates were resolved by 12% SDS-PAGE, transferred to a nitrocellulose membrane, and subjected to immunoblot analysis with antibodies specific for the total or phosphorylated forms of (A) p38 MAPK (phospho-p38 MAPK [T183/Y185] antibody); (B) JNK/SAPK (phospho-JNK/SAPK [T180/Y182] antibody); and (C) ERK1/2 (p44/42) (phospho-p44/42 MAPK [T202/Y204] antibody). Blots shown are from one donor and are representative of 5 experiments using different donors that yielded similar results. MDMs were stimulated with JRFL gp120 or MIP-1 and cell lysates were analyzed by Western blot using polyclonal antibodies specific for the dually phosphorylated forms of the 3 members of the MAPK superfamily, extracellular regulated kinase (ERK1/2), JNK/SAPK, and p38 MAPK. Stimulation of macrophages with both JRFL gp120 and MIP-1 resulted in the rapid phosphorylation of p38 MAPK (Figure 5A) and JNK/SAPK (Figure 5B). In contrast, we observed a high basal level of phosphorylation in the case of p44/42 MAPK, and no further activation was elicited by either Env or chemokine (Figure 5C). The kinetics of MAPK activation were similar to those observed for Pyk2, peaking at about 5 minutes of exposure. Stimulation with SDF-1 also led to p38 and JNK/SAPK MAPK phosphorylation, although activation by IIIB gp120 was inconsistent (data not shown). Involvement of MAPK signaling pathway in gp120-mediated chemokine induction We next addressed the important question of whether gp120-induced chemokine receptor-mediated signaling in macrophages results in functional consequences with potential biologic significance. Macrophages are a major source for the production of -chemokines, which play a central role in inflammatory cell recruitment and activation.44 Changes in the production of specific chemokines have been demonstrated during the course of HIV infection and, particularly, in compartments where macrophages are believed to be important in pathogenesis.45-47 In addition, several groups have observed increased production of -chemokines by macrophages after in vitro HIV infection or gp120 exposure.48-50 Therefore, we investigated gp120-induced chemokine secretion by human macrophages and whether the MAPK pathway might be involved. The MDMs were exposed to JRFL gp120 for 24 hours, and MIP-1 and MCP-1 concentrations in the clarified culture supernatants were measured by ELISA (Figure 6). Treatment with gp120 (1 µg/mL) up-regulated macrophage MCP-1 and MIP-1 production, up to 25 000 pg/mL and 12 000 pg/mL, respectively. No response was seen if gp120 was subjected to heat inactivation prior to MDM stimulation (data not shown). PTX did not inhibit gp120-induced MCP-1 and MIP-1 secretion, whereas induction was completely blocked by herbimycin, a broad-spectrum tyrosine kinase antagonist (data not shown). We then tested SB-202190, a specific inhibitor of MAPK activation.51 Pretreatment with SB-202190 completely abrogated gp120 induction of MIP-1 and MCP-1 in primary macrophages (Figure 6), without any evidence of cellular toxicity. Identical results were seen with gp120 at 2.5 µg/mL (data not shown). Thus, gp120 stimulates macrophage -chemokine production through a MAPK-dependent pathway. Up-regulation of -chemokine production by gp120 in macrophages may modulate subsequent rounds of infection by coreceptor blocking52 or, conversely, contribute to enhanced viral spread by new target cell recruitment and inflammatory consequences. View larger version (35K): [in this window] [in a new window]   Figure 6. MAPK activation is involved in gp120-induced chemokine secretion. MDMs were preincubated for 1 hour with or without the specific MAPK inhibitor SB-202190 (1 µg/mL) and then exposed to JRFL gp120 (1 µg/mL). After 24 hours of culture, supernatants were harvested. Levels of MIP-1 (A) and MCP-1 (B) and in the clarified supernatants were then detected by ELISA. Data are the mean of duplicate samples ± SD and one representative experiment of 4 is shown.     Discussion Top Abstract Introduction Materials and methods Results Discussion References Engagement of the chemokine receptor entry coreceptors by HIV-1 Env is essential for membrane fusion, but it may also initiate signaling events that alter cellular functions or even affect postentry stages of infection. Studies to date indicate that HIV-1 gp120 may participate in several signaling pathways through these receptors, including those involving G protein stimulation, ionic signaling, and protein phosphorylation.2 Macrophages are important targets for HIV-1 in vivo and express both CCR5 and CXCR4, the principal coreceptors for HIV-1 entry. However, relatively little is known about the pathways by which chemokine receptors signal in primary human macrophages in response to either gp120 or their natural chemokine ligands. We recently demonstrated that HIV-1 Env activates ionic signaling responses in macrophages through CCR5 and CXCR4.20 In the present study, we show that Env interaction with the coreceptors results in phosphorylation of the protein tyrosine kinase Pyk2, activation of the p38 and JNK/SAPK MAP kinases, and consequent induction of chemoattractant proinflammatory mediator secretion. These results begin to delineate the pathways by which the chemokine receptors are coupled in primary macrophages and, importantly, identify mechanisms by which HIV-1 may subvert the normal cellular signaling machinery. Protein kinase activation by gp120 had not previously been examined in macrophages. We focused on the FAK-related protein Pyk2, also known as related adhesion focal tyrosine kinase (RAFTK),24 calcium-dependent protein tyrosine kinase (CADTK),36 or cell adhesion kinase  (CAK),26 because this tyrosine kinase provides a potential link between chemokine receptor activation and multiple downstream intracellular pathways.53 Moreover, Pyk2 activation may modulate ion channel function in certain cells,25,27 and we recently demonstrated ion channel activation by gp120 in macrophages.20 In this study we found that both R5 and X4 gp120 activate Pyk2 in primary macrophages. Activation is mediated specifically by CCR5 and CXCR4, and not by CD4, because no increase in phosphorylation was observed following Env binding to CD4 in CCR5 MDMs stimulated with JRFL and in AMD3100-treated macrophages stimulated with IIIB gp120. Supporting the idea that the chemokine receptors specifically mediate this signal, Pyk2 activation was also seen following stimulation by the natural chemokine ligands. Pyk2 activation has been reported in T cells following CCR5 and CXCR4 stimulation by chemokines and gp120,5,6,29,54 as has the related FAK following gp120 stimulation.4 Thus, our data extend these findings to primary macrophages, an important target for HIV-1 infection in vivo, to show that CCR5 and CXCR4 are linked to the protein kinase Pyk2 in macrophages, and that both R5 and X4 gp120 are functional agonists for this pathway. We found that [Ca++]i elevation mediated by CRAC channels is a principal link between CCR5 stimulation and Pyk2 activation in macrophages, because both EGTA and the CRAC channel inhibitor lanthanum blocked gp120-induced Pyk2 phosphorylation. This result is in accord with our previous finding that gp120 elevates macrophage cytosolic calcium,20 and observations by others that Pyk2 activation is linked to [Ca++]i in various cell types.25,27,30,31,36 We also found that CCR5-mediated Pyk2 activation in macrophages was insensitive to PTX, indicating that it is not coupled through Gi. Both PTX-sensitive and PTX-insensitive signaling through CCR5 and CXCR4 in lymphocytes has been reported for chemokines55-57 and gp120.4,5 Our finding that chemokine and Env signalings in macrophages were both insensitive to PTX suggests that these receptors are coupled in MDMs to G proteins other than Gi, although it is also possible that alternative signaling pathways independent of G proteins may be responsible as has recently been described for several other GPCRs.58,59 Of note, it has been demonstrated that the G proteins with which a GPCR are coupled may differ depending on the cell type.19 Thus, our observation of PTX-insensitive CCR5 signaling in macrophages supports the notion that these signal transduction events are highly cell specific and emphasize the importance of defining these pathways in the relevant primary cell type of interest. Because Pyk2 is implicated as an upstream regulator of the MAPK family of proteins in a variety of cell types,28,29,31,36,42,43 we examined MAPK activity in macrophages and found that JRFL gp120 as well as chemokines triggered activation of p38 and JNK/SAPK MAPK. HIV-1- or gp120-induced MAP kinase activation has been reported in T cells, where it may play a role in regulating viral expression.7,8,60,61 Like Pyk2, activation of macrophage MAPK was not blocked by PTX, indicating that it is independent of Gi. In other cell types, both Gi- and Gq-coupled pathways have been associated with GPCR activation of MAPKs.28,62 Because specific inhibitors of Pyk2 activation are currently not available, we were unable to definitively determine whether MAPK stimulation is Pyk2-dependent. We did find, however, that gp120-induced p38 phosphorylation was largely inhibited by blocking Ca++ influx (data not shown), which is consistent with the possibility that Pyk2 may be an upstream mediator of gp120-elicited MAPK activation. A central question regarding these data involves the biologic significance of signaling cascades induced by gp120 in macrophages. MAPK activation plays an important role in regulating inflammatory responses, such as cytokine secretion in response to multiple stimuli.7,61,63-66 HIV-1 exposure or infection may induce a variety of functional and secretory responses in primary macrophages,13,48,50,67 including gp120-induced secretion of -chemokines.49 Therefore, we investigated whether the MAPK signaling pathway might be involved in gp120-mediated -chemokine induction. We found that gp120 stimulation of macrophages induced the production of both MIP-1 and MCP-1, potent chemoattractants for monocytes and macrophages, and that this response was blocked by MAPK inhibition, implicating this pathway in the macrophage secretory response to gp120. Thus, although the exact relationships between Pyk2, MAPK, ionic signaling, and [Ca++]i in coreceptor-mediated -chemokine secretion in response to gp120 remains to be fully elucidated, the interaction of HIV-1 Env with the chemokine receptors on macrophages can result in the activation of signaling pathways and lead to proinflammatory responses even in the absence of infection. Coreceptor signaling is dispensable for infection in cell lines,55,68 but indirect evidence has suggested that signaling might modulate infection in primary cells. Desensitization of CCR5 signaling has been associated with inhibition of lymphocyte infection,69 and chemokine receptor-mediated signaling was recently implicated in modulating productive versus nonproductive macrophage infection.37 Thus, whether signaling pathways elicited by Env in primary macrophages are involved in cell- and virus-specific mechanisms that modulate infection subsequent to entry is an important question that remains to be fully defined. In addition to Env on infectious virions, macrophages may be exposed to gp120 on the surface of noninfectious virions or as free protein in tissues or into the circulation of infected subjects.70,71 Concentrations of gp120 in circulation up to 92 ng/mL have been reported,71 which is close to the level seen to activate Pyk2 here. Furthermore, we found chemokine secretion induced by as little as 50 ng/mL gp120 (data not shown). Importantly, however, macrophages are likely to be exposed to Env glycoprotein in vivo within tissues, where higher concentrations of gp120 may be achieved locally at sites of viral replication and contribute to induction of kinase activation. Thus, the activation pathways identified in this report may also contribute to pathogenesis through interactions with uninfected cells. Various abnormalities of macrophage functions have been observed in HIV-1 infection in vivo and in vitro that in many cases can be induced by virions or soluble gp120 even in the absence of infection.13,15,72 Also, although -chemokines have the potential to block R5 viral entry,52 dysregulated chemokine secretion may also promote the recruitment of uninfected cells to sites of active viral replication, promoting viral spread.73 In the central nervous system (CNS) of individuals with HIV encephalopathy (HIVE), infected macrophages and microglia are necessary for the development of HIVE, but clinical disease appears to be most closely related to the degree of macrophage and microglia activation.10,74 Elevated levels of -chemokines are found in the CNS of individuals with HIVE45,46,50,75 and animals with simian immunodeficiency virus encephalopathy.47 Therefore, macrophage/microglia activation may contribute to pathogenesis through release of soluble mediators that themselves may be neurotoxic, including -chemokines,76 or indirectly through leukocyte recruitment into the CNS.75,77 Thus, our studies elucidate specific gp120-mediated macrophage activation pathways that may lead to macrophage activation and dysfunction and contribute to pathogenesis in vivo.     Acknowledgments We thank J. Cutilli, J. Riess and J. Moschella for technical assistance; R. Doms for Env proteins and valuable discussions; and blood donors who generously provided cells.     Footnotes Submitted April 24, 2001; accepted July 16, 2001. Supported in part by grants from the National Institutes of Health (MH 61139, AI 35502, and HL 58004) and from the Italian Ministry of Health (40D.7). The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Ronald Collman, 522 Johnson Pavilion, 36th and Hamilton Walk, Philadelphia, PA 19104; e-mail: collmanr{at}mail.med.upenn.edu.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657-700[CrossRef][Medline] [Order article via Infotrieve]. 2. Popik W, Pitha PM. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 2000;276:1-6[CrossRef][Medline] [Order article via Infotrieve]. 3. Weissman D, Rabin RL, Arthos J, et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 1997;389:981-985[CrossRef][Medline] [Order article via Infotrieve]. 4. Cicala C, Arthos J, Ruiz M, et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. J Immunol. 1999;163:420-426[Abstract/Free Full Text]. 5. Davis CB, Dikic I, Unutmaz D, et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med. 1997;186:1793-1798[Abstract/Free Full Text]. 6. Missé D, Cerutti M, Noraz N, et al. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. Blood. 1999;93:2454-2462[Abstract/Free Full Text]. 7. Popik W, Hesselgesser JE, Pitha PM. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol. 1998;72:6406-6413[Abstract/Free Full Text]. 8. Popik W, Pitha PM. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Virology. 1998;252:210-217[CrossRef][Medline] [Order article via Infotrieve]. 9. Igarashi T, Brown CR, Endo Y, et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A. 2001;98:658-663[Abstract/Free Full Text]. 10. Kolson DL, Lavi E, González-Scarano F. The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res. 1998;50:1-47[Medline] [Order article via Infotrieve]. 11. Martin JC, Bandres JC. Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection. J Acquir Immune Defic Syndr. 1999;22:413-429. 12. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science. 1997;276:1857-1861[Abstract/Free Full Text]. 13. Borghi P, Fantuzzi L, Varano B, et al. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol. 1995;69:1284-1287[Abstract]. 14. Koziel H, Eichbaum Q, Kruskal BA, et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest. 1998;102:1332-1344[Medline] [Order article via Infotrieve]. 15. Shiratsuchi H, Johnson JL, Toossi Z, Ellner JJ. Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest. 1994;93:885-891. 16. Simmons G, Reeves JD, McKnight A, et al. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol. 1998;72:8453-8457[Abstract/Free Full Text]. 17. Verani A, Pesenti E, Polo S, et al. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Immunol. 1998;161:2084-2088[Abstract/Free Full Text]. 18. Yi Y, Isaacs SN, Williams DA, et al. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol. 1999;73:7117-7125[Abstract/Free Full Text]. 19. Arai H, Charo IF. Differential regulation of G-protein-mediated signaling by chemokine receptors. J Biol Chem. 1996;271:21814-21819[Abstract/Free Full Text]. 20. Liu QH, Williams DA, McManus C, et al. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci U S A. 2000;97:4832-4837[Abstract/Free Full Text]. 21. Collman R, Hassan NF, Walker R, et al. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med. 1989;170:1149-1163[Abstract/Free Full Text]. 22. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature. 1996;382:722-725[CrossRef][Medline] [Order article via Infotrieve]. 23. Edinger AL, Blanpain C, Kunstman KJ, et al. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J Virol. 1999;73:4062-4073[Abstract/Free Full Text]. 24. Avraham S, London R, Fu Y, et al. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem. 1995;270:27742-27751[Abstract/Free Full Text]. 25. Lev S, Moreno H, Martinez R, et al. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 1995;376:737-745[CrossRef][Medline] [Order article via Infotrieve]. 26. Sasaki H, Nagura K, Ishino M, et al. Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem. 1995;270:21206-21219[Abstract/Free Full Text]. 27. Dikic I, Dikic I, Schlessinger J. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. J Biol Chem. 1998;273:14301-14308[Abstract/Free Full Text]. 28. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 1996;383:547-550[CrossRef][Medline] [Order article via Infotrieve]. 29. Ganju RK, Dutt P, Wu L, et al. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood. 1998;91:791-797[Abstract/Free Full Text]. 30. Soltoff SP. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation. J Biol Chem. 1998;273:23110-23117[Abstract/Free Full Text]. 31. Tokiwa G, Dikic I, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science. 1996;273:792-794[Abstract]. 32. Li X, Hunter D, Morris J, Haskill JS, Earp HS. A calcium-dependent tyrosine kinase splice variant in human monocytes. Activation by a two-stage process involving adherence and a subsequent intracellular signal. J Biol Chem. 1998;273:9361-9364[Abstract/Free Full Text]. 33. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833-835[CrossRef][Medline] [Order article via Infotrieve]. 34. Schols D, Struyf S, Van Damme J, et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med. 1997;186:1383-1388[Abstract/Free Full Text]. 35. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377[CrossRef][Medline] [Order article via Infotrieve]. 36. Yu H, Li X, Marchetto GS, et al. Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation. J Biol Chem. 1996;271:29993-29998[Abstract/Free Full Text]. 37. Arthos J, Rubbert A, Rabin RL, et al. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J Virol. 2000;74:6418-6424[Abstract/Free Full Text]. 38. Aussel C, Marhaba R, Pelassy C, Breittmayer JP. Submicromolar La3+ concentrations block the calcium release-activated channel, and impair CD69 and CD25 expression in CD3- or thapsigargin-activated Jurkat cells. Biochem J. 1996;313 (pt 3):909-913. 39. Floto RA, Mahaut-Smith MP, Allen JM, Somasundaram B. Differentiation of the human monocytic cell line U937 results in an upregulation of the calcium release-activated current, ICRAC. J Physiol. 1996;495:331-338[Abstract/Free Full Text]. 40. Ui M, Katada T. Bacterial toxins as probe for receptor-Gi coupling. Adv Second Messenger Phosphoprotein Res. 1990;24:63-69[Medline] [Order article via Infotrieve]. 41. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843-14846[Free Full Text]. 42. Della Rocca GJ, van Biesen T, Daaka Y, et al. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997;272:19125-19132[Abstract/Free Full Text]. 43. Pandey P, Avraham S, Kumar S, et al. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J Biol Chem. 1999;274:10140-10144[Abstract/Free Full Text]. 44. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568[CrossRef][Medline] [Order article via Infotrieve]. 45. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 1998;12:1327-1332[Medline] [Order article via Infotrieve]. 46. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. -Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol. 1998;44:831-835[CrossRef][Medline] [Order article via Infotrieve]. 47. Sasseville VG, Smith MM, Mackay CR, et al. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol. 1996;149:1459-1467[Abstract]. 48. Canque B, Rosenzwajg M, Gey A, et al. Macrophage inflammatory protein-1 is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood. 1996;87:2011-2019[Abstract/Free Full Text]. 49. Fantuzzi L, Canini I, Belardelli F, Gessani S. HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J Immunol. 2001;166:5381-5387[Abstract/Free Full Text]. 50. Schmidtmayerova H, Nottet HSLM, Nuovo G, et al. Human immunodeficiency virus type 1 infection alters chemokine  peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A. 1996;93:700-704[Abstract/Free Full Text]. 51. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105[CrossRef][Medline] [Order article via Infotrieve]. 52. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811-1815[Abstract/Free Full Text]. 53. Avraham H, Park SY, Schinkmann K, Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 2000;12:123-133[CrossRef][Medline] [Order article via Infotrieve]. 54. Ganju RK, Brubaker SA, Meyer J, et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998;273:23169-23175[Abstract/Free Full Text]. 55. Farzan M, Choe H, Martin KA, et al. HIV-1 entry and macrophage inflammatory protein-1-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem. 1997;272:6854-6857[Abstract/Free Full Text]. 56. Wong M, Fish EN. RANTES and MIP-1alpha activate STATs in T cells. J Biol Chem. 1998;273:309-314[Abstract/Free Full Text]. 57. Zhao J, Ma L, Wu YL, et al. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem. 1998;71:36-45[CrossRef][Medline] [Order article via Infotrieve]. 58. Hall RA, Spurney RF, Premont RT, et al. G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem. 1999;274:24328-24334[Abstract/Free Full Text]. 59. Heuss C, Gerber U. G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci. 2000;23:469-475[CrossRef][Medline] [Order article via Infotrieve]. 60. Cohen PS, Schmidtmayerova H, Dennis J, et al. The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med. 1997;3:339-346[Medline] [Order article via Infotrieve]. 61. Shapiro L, Heidenreich KA, Meintzer MK, Dinarello CA. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc Natl Acad Sci U S A. 1998;95:7422-7426[Abstract/Free Full Text]. 62. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 1997;9:337-351[CrossRef][Medline] [Order article via Infotrieve]. 63. Kutsch O, Oh J, Nath A, Benveniste EN. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol. 2000;74:9214-9221[Abstract/Free Full Text]. 64. Means TK, Pavlovich RP, Roca D, Vermeulen MW, Fenton MJ. Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukoc Biol. 2000;67:885-893[Abstract]. 65. Park IW, Wang JF, Groopman JE. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood. 2001;97:352-358[Abstract/Free Full Text]. 66. Sodhi A, Montaner S, Patel V, et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 2000;60:4873-4880[Abstract/Free Full Text]. 67. Gessani S, Borghi P, Fantuzzi L, et al. Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation. J Leukoc Biol. 1997;62:49-53[Abstract]. 68. Atchison RE, Gosling J, Monteclaro FS, et al. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science. 1996;274:1924-1926[Abstract/Free Full Text]. 69. Alfano M, Schmidtmayerova H, Amella CA, Pushkarsky T, Bukrinsky M. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J Exp Med. 1999;190:597-605[Abstract/Free Full Text]. 70. Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS. 2000;14:2709-2713[CrossRef][Medline] [Order article via Infotrieve]. 71. Oh SK, Cruikshank WW, Raina J, et al. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr. 1992;5:251-256. 72. Merrill JE, Koyanagi Y, Zack J, et al. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol. 1992;66:2217-2225[Abstract/Free Full Text]. 73. Tedla N, Palladinetti P, Kelly M, et al. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol. 1996;148:1367-1373[Abstract]. 74. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995;38:755-762[CrossRef][Medline] [Order article via Infotrieve]. 75. Sanders VJ, Pittman CA, White MC, et al. Chemokines and receptors in HIV encephalitis. AIDS. 1998;12:1021-1026[CrossRef][Medline] [Order article via Infotrieve]. 76. Galasso JM, Liu Y, Szaflarski J, Warren JS, Silverstein FS. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain. Neuroscience. 2000;101:737-744[CrossRef][Medline] [Order article via Infotrieve]. 77. Persidsky Y, Ghorpade A, Rasmussen J, et al. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol. 1999;155:1599-1611[Abstract/Free Full Text]. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: G. Vasiliver-Shamis, M. W. Cho, C. E. Hioe, and M. L. Dustin Human Immunodeficiency Virus Type 1 Envelope gp120-Induced Partial T-Cell Receptor Signaling Creates an F-Actin-Depleted Zone in the Virological Synapse J. Virol., November 1, 2009; 83(21): 11341 - 11355. [Abstract] [Full Text] [PDF] A. R. Anand, A. Prasad, R. R. Bradley, Y. S. Deol, T. Nagaraja, X. Ren, E. F. Terwilliger, and R. K. Ganju HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1 Blood, October 22, 2009; 114(17): 3588 - 3600. [Abstract] [Full Text] [PDF] R. Cheung, M. Malik, V. Ravyn, B. Tomkowicz, A. Ptasznik, and R. G. Collman An arrestin-dependent multi-kinase signaling complex mediates MIP-1{beta}/CCL4 signaling and chemotaxis of primary human macrophages J. Leukoc. Biol., October 1, 2009; 86(4): 833 - 845. [Abstract] [Full Text] [PDF] M. Del Corno, A. Michienzi, A. Masotti, L. Da Sacco, G. F. Bottazzo, F. Belardelli, and S. Gessani CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells Blood, July 23, 2009; 114(4): 796 - 806. [Abstract] [Full Text] [PDF] A. N. Harman, M. Kraus, C. R. Bye, K. Byth, S. G. Turville, O. Tang, S. K. Mercier, N. Nasr, J. L. Stern, B. Slobedman, et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase Blood, July 2, 2009; 114(1): 85 - 94. [Abstract] [Full Text] [PDF] L. Achour, M. G. H. Scott, H. Shirvani, A. Thuret, G. Bismuth, C. Labbe-Jullie, and S. Marullo CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface Blood, February 26, 2009; 113(9): 1938 - 1947. [Abstract] [Full Text] [PDF] R. Sengupta, S. Burbassi, S. Shimizu, S. Cappello, R. B. Vallee, J. B. Rubin, and O. Meucci Morphine Increases Brain Levels of Ferritin Heavy Chain Leading to Inhibition of CXCR4-Mediated Survival Signaling in Neurons J. Neurosci., February 25, 2009; 29(8): 2534 - 2544. [Abstract] [Full Text] [PDF] A. Braun, J. E. Gessner, D. Varga-Szabo, S. N. Syed, S. Konrad, D. Stegner, T. Vogtle, R. E. Schmidt, and B. Nieswandt STIM1 is essential for Fc{gamma} receptor activation and autoimmune inflammation Blood, January 29, 2009; 113(5): 1097 - 1104. [Abstract] [Full Text] [PDF] M. Malik, Y.-Y. Chen, M. F. Kienzle, B. E. Tomkowicz, R. G. Collman, and A. Ptasznik Monocyte Migration and LFA-1-Mediated Attachment to Brain Microvascular Endothelia Is Regulated by SDF-1{alpha} through Lyn Kinase J. Immunol., October 1, 2008; 181(7): 4632 - 4637. [Abstract] [Full Text] [PDF] B. Harmon and L. Ratner Induction of the G{alpha}q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry J. Virol., September 15, 2008; 82(18): 9191 - 9205. [Abstract] [Full Text] [PDF] H. W. van Deventer, Q. P. Wu, D. T. Bergstralh, B. K. Davis, B. P. O'Connor, J. P.-Y. Ting, and J. S. Serody C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9 Am. J. Pathol., July 1, 2008; 173(1): 253 - 264. [Abstract] [Full Text] [PDF] R. Cheung, V. Ravyn, L. Wang, A. Ptasznik, and R. G. Collman Signaling Mechanism of HIV-1 gp120 and Virion-Induced IL-1{beta} Release in Primary Human Macrophages J. Immunol., May 15, 2008; 180(10): 6675 - 6684. [Abstract] [Full Text] [PDF] L. Fantuzzi, F. Spadaro, C. Purificato, S. Cecchetti, F. Podo, F. Belardelli, S. Gessani, and C. Ramoni Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages Blood, April 1, 2008; 111(7): 3355 - 3363. [Abstract] [Full Text] [PDF] S. A. Trushin, A. Algeciras-Schimnich, S. R. Vlahakis, G. D. Bren, S. Warren, D. J. Schnepple, and A. D. Badley Glycoprotein 120 Binding to CXCR4 Causes p38-Dependent Primary T Cell Death That Is Facilitated by, but Does Not Require Cell-Associated CD4 J. Immunol., April 15, 2007; 178(8): 4846 - 4853. [Abstract] [Full Text] [PDF] S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF] M. M. Lederman, A. Penn-Nicholson, M. Cho, and D. Mosier Biology of CCR5 and its role in HIV infection and treatment. JAMA, August 16, 2006; 296(7): 815 - 826. [Abstract] [Full Text] [PDF] B. Tomkowicz, C. Lee, V. Ravyn, R. Cheung, A. Ptasznik, and R. G. Collman The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages Blood, August 15, 2006; 108(4): 1145 - 1150. [Abstract] [Full Text] [PDF] Z. Sui, S. Fan, L. Sniderhan, E. Reisinger, A. Litzburg, G. Schifitto, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation J. Immunol., July 1, 2006; 177(1): 702 - 711. [Abstract] [Full Text] [PDF] M. Del Corno, M. C. Gauzzi, G. Penna, F. Belardelli, L. Adorini, and S. Gessani Human Immunodeficiency Virus Type 1 gp120 and Other Activation Stimuli Are Highly Effective in Triggering Alpha Interferon and CC Chemokine Production in Circulating Plasmacytoid but Not Myeloid Dendritic Cells J. Virol., October 1, 2005; 79(19): 12597 - 12601. [Abstract] [Full Text] [PDF] C. Lee, B. Tomkowicz, B. D. Freedman, and R. G. Collman HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways J. Leukoc. Biol., October 1, 2005; 78(4): 1016 - 1023. [Abstract] [Full Text] [PDF] G. H. Holm and D. Gabuzda Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions J. Virol., May 15, 2005; 79(10): 6299 - 6311. [Abstract] [Full Text] [PDF] N. Vazquez, T. Greenwell-Wild, N. J. Marinos, W. D. Swaim, S. Nares, D. E. Ott, U. Schubert, P. Henklein, J. M. Orenstein, M. B. Sporn, et al. Human Immunodeficiency Virus Type 1-Induced Macrophage Gene Expression Includes the p21 Gene, a Target for Viral Regulation J. Virol., April 1, 2005; 79(7): 4479 - 4491. [Abstract] [Full Text] [PDF] Y. Yi, F. Shaheen, and R. G. Collman Preferential Use of CXCR4 by R5X4 Human Immunodeficiency Virus Type 1 Isolates for Infection of Primary Lymphocytes J. Virol., February 1, 2005; 79(3): 1480 - 1486. [Abstract] [Full Text] [PDF] K. Nakamichi, S. Inoue, T. Takasaki, K. Morimoto, and I. Kurane Rabies Virus Stimulates Nitric Oxide Production and CXC Chemokine Ligand 10 Expression in Macrophages through Activation of Extracellular Signal-Regulated Kinases 1 and 2 J. Virol., September 1, 2004; 78(17): 9376 - 9388. [Abstract] [Full Text] [PDF] S. E. Pontow, N. V. Heyden, S. Wei, and L. Ratner Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell Fusion J. Virol., July 1, 2004; 78(13): 7138 - 7147. [Abstract] [Full Text] [PDF] G. H. Holm, C. Zhang, P. R. Gorry, K. Peden, D. Schols, E. De Clercq, and D. Gabuzda Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure J. Virol., May 1, 2004; 78(9): 4541 - 4551. [Abstract] [Full Text] [PDF] H. Kan, Z. Xie, and M. S. Finkel p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes Am J Physiol Cell Physiol, January 1, 2004; 286(1): C1 - C7. [Abstract] [Full Text] [PDF] S. M. Wahl, T. Greenwell-Wild, G. Peng, G. Ma, J. M. Orenstein, and N. Vazquez Viral and host cofactors facilitate HIV-1 replication in macrophages J. Leukoc. Biol., November 1, 2003; 74(5): 726 - 735. [Abstract] [Full Text] [PDF] C. Lee, Q.-H. Liu, B. Tomkowicz, Y. Yi, B. D. Freedman, and R. G. Collman Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways J. Leukoc. Biol., November 1, 2003; 74(5): 676 - 682. [Abstract] [Full Text] [PDF] E. Gross, C. A. Amella, L. Pompucci, G. Franchin, B. Sherry, and H. Schmidtmayerova Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 781 - 790. [Abstract] [Full Text] [PDF] I. S. Zeelenberg, L. Ruuls-Van Stalle, and E. Roos The Chemokine Receptor CXCR4 Is Required for Outgrowth of Colon Carcinoma Micrometastases Cancer Res., July 1, 2003; 63(13): 3833 - 3839. [Abstract] [Full Text] [PDF] F. Francois and M. E. Klotman Phosphatidylinositol 3-Kinase Regulates Human Immunodeficiency Virus Type 1 Replication following Viral Entry in Primary CD4+ T Lymphocytes and Macrophages J. Virol., February 15, 2003; 77(4): 2539 - 2549. [Abstract] [Full Text] [PDF] G. Lin, F. Baribaud, J. Romano, R. W. Doms, and J. A. Hoxie Identification of gp120 Binding Sites on CXCR4 by Using CD4-Independent Human Immunodeficiency Virus Type 2 Env Proteins J. Virol., December 20, 2002; 77(2): 931 - 942. [Abstract] [Full Text] [PDF] S. Kinet, F. Bernard, C. Mongellaz, M. Perreau, F. D. Goldman, and N. Taylor gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4+ lymphocytes Blood, September 18, 2002; 100(7): 2546 - 2553. [Abstract] [Full Text] [PDF] A. Papkalla, J. Munch, C. Otto, and F. Kirchhoff Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity and Replication Independently of Viral Coreceptor Tropism J. Virol., July 17, 2002; 76(16): 8455 - 8459. [Abstract] [Full Text] [PDF] C. Cicala, J. Arthos, S. M. Selig, G. Dennis Jr., D. A. Hosack, D. Van Ryk, M. L. Spangler, T. D. Steenbeke, P. Khazanie, N. Gupta, et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication PNAS, July 9, 2002; 99(14): 9380 - 9385. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Del Corno, M. Articles by Collman, R. G. Search for Related Content PubMed PubMed Citation Articles by Del Corno, M. Articles by Collman, R. G. Related Collections Signal Transduction Chemokines, Cytokines, and Interleukins Social Bookmarking                   What's this?

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020